Expanding Cervical Cancer Screening in Mozambique: Challenges Associated With Diagnosing and Treating Cervical Cancer
- PMID: 37824802
- PMCID: PMC10664858
- DOI: 10.1200/GO.23.00139
Expanding Cervical Cancer Screening in Mozambique: Challenges Associated With Diagnosing and Treating Cervical Cancer
Abstract
Purpose: Mozambique has one of the highest burdens of cervical cancer globally. Treatment options are few as most women present with advanced disease, and there are limited trained health professionals and health care resources. The objective of this study was to describe the outcomes of women diagnosed with invasive cancer as part of the Mozambican women undergoing cervical cancer screening with human papillomavirus (HPV) testing in conjunction with family planning services (MULHER) study.
Materials and methods: Women age 30-49 years were prospectively enrolled in the MULHER study and offered screening with primary HPV testing followed by treatment of screen-positive women with thermal ablation or excision as appropriate. Women with cervical examination findings suspicious for cancer were referred to one of the three gynecologic oncologists in the country.
Results: Between January 2020 and January 2023, 9,014 women underwent cervical cancer screening and 30 women were diagnosed with cervical cancer. In this cohort, four patients (13.3%) had early-stage disease, 18 (60.0%) had locally advanced disease, one (3.3%) had distant metastatic disease, and seven (23.3%) did not have staging information available. Five patients (16.6%) died without receiving oncologic treatment, and seven patients (23.3%) are still awaiting treatment. Of the remaining 18 patients, three (17.6%) underwent surgery and four (23.5%) received radiotherapy. Eleven (36.7%) patients received only chemotherapy.
Conclusion: As cervical screening programs are implemented in low-resource settings, there will likely be an increase in the number of women diagnosed with invasive cervical cancer. Our results in Mozambique demonstrate the need to increase access to advanced surgery, radiation, and palliative care services.
Conflict of interest statement
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (
Figures


References
-
- https://data.worldbank.org/indicator/SP.POP.TOTL.FE.ZS?locations=MZ Mozambique. The World Bank.
-
- https://gco.iarc.fr/today/data/factsheets/populations/508-mozambique-fac... Global cancer Mozambique. World Health Organization.
-
- https://www.cdc.gov/globalhivtb/where-we-work/Mozambique.pdf Mozambique: CDC Division of Global HIV and TB Country Profile. Centers for Disease Control & Prevention.
-
- Osman N. S10.2 cervical cancer screening: Benefits and challenges of HPV self-sampling in Mozambique. Sex Transm Infect. 2021;97:A14 LP-A14. suppl 1.
-
- Patel JD, Galsky MD, Chagpar AB, et al. Role of American Society of Clinical Oncology in low- and middle-income countries. J Clin Oncol. 2011;29:3097–3102. - PubMed